Trial Profile
Salvage Therapy With Trabectedin in Metastatic Pancreatic Adenocarcinoma: A Single-Arm Phase II Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Oct 2016
Price :
$35
*
At a glance
- Drugs Trabectedin (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Acronyms PACT-18
- 09 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 26 Apr 2011 New trial record